Peter van der Velden is the Managing General Partner of Lumira Ventures (also known as Lumira Capital). See sector focus and contact routes.
Peter van der Velden is the Managing General Partner of Lumira Ventures (also known as Lumira Capital), Canada’s largest dedicated life sciences venture capital firm, with 28 years of experience building technology-centric companies from startup to expansion. His investment thesis focuses on transformative biopharmaceutical, medical device, and digital health companies located in North America, targeting the full lifecycle from start-up through expansion. While specific check sizes and lead/follow behavior are not publicly detailed, Lumira’s scope implies active involvement across early and growth stages in the life sciences sector. Notable portfolio companies include those supported through Lumira’s partnership with the Terry Fox Foundation to launch the Cancer Breakthrough Fund, though specific named companies beyond this initiative are not cited in available sources. Van der Velden is a frequent lecturer at Canadian universities on venture capital, innovation, and healthcare, and serves on multiple boards including the World Health Innovation Network and Sick Kids Hospital’s Commercialization Advisory Board. He was appointed to the Ontario Health Innovation Cou
StartupFundraising tracks this investor record from SEC filings and announced rounds, updating focus, location and portfolio history as new data lands. Use it to gauge fit before an outreach, then widen the search to investors in Toronto.
Investors like Peter van der Velden · Full investor directory · Investor access · Company funding database